A detailed history of Total Investment Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Total Investment Management Inc holds 549 shares of GILD stock, worth $68,119. This represents 0.01% of its overall portfolio holdings.

Number of Shares
549
Holding current value
$68,119
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 29, 2025

BUY
$96.91 - $113.0 $53,203 - $62,037
549 New
549 $60,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $156B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Total Investment Management Inc Portfolio

Follow Total Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Total Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Total Investment Management Inc with notifications on news.